Tasso, a Seattle-based telemedicine company that specializes in remote, self-sampled blood collection, has raised $17 million in a series A round of funding. The telehealth market has boomed over the ...

Tasso has taken a major step forward in its plans to make quick, easy and widespread blood tests a reality, with an FDA clearance for its simple sample collection device. The Tasso+ lancet can be ...

Tasso and Arup Laboratories have formed a collaboration for developing and ‘operationalising’ at-home, blood testing services, offering support to clinical research. By combining Tasso’s ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the launch of its next generation technology for dried blood ...

Leading European pharmaceutical companies are using the device across multiple virtual clinical trials to gather unprecedented amounts of pharmacokinetic data SEATTLE--(BUSINESS WIRE)--Tasso Inc., a ...

Tasso has received $17 million in new funding to scale up production of its self-administered blood collection devices, designed to help enable telemedicine and diagnostic testing from the home. The ...

Athlete-centric blood collection joint offering returns for its second Olympic Games as demand for modern anti-doping solutions intensifies worldwide COLORADO SPRINGS, Colo. & SEATTLE, February 04, ...

Neurogen Biomarking has entered a collaboration to adopt Tasso’s needle-free blood collection technology into its at-home Alzheimer’s testing platform. The collaboration will see Neurogen's brain ...